{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T15:46:48Z","timestamp":1775749608364,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s00520-015-3000-6","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T03:19:25Z","timestamp":1446607165000},"page":"1001-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review"],"prefix":"10.1007","volume":"24","author":[{"given":"Ronald","family":"Chow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolph","family":"Navari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Passik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Pasetka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"DeAngelis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"issue":"4","key":"3000_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s005200050078","volume":"5","author":"D Osoba","year":"1997","unstructured":"Osoba D, Zee B, Warr D, Latreille J, Kaizer L, Pater J (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. Support Care Cancer 5(4):307\u2013313","journal-title":"Support Care Cancer"},{"key":"3000_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","volume":"14","author":"FP Bymaster","year":"1996","unstructured":"Bymaster FP, Calligaro D, Falcone J, Marsh R, Moore N, Tye N et al (1996) Radio-receptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87\u201396","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"3000_CR3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0885-3924(03)00143-X","volume":"25","author":"M Srivastava","year":"2003","unstructured":"Srivastava M, Brito-Dellan N, Davis MP, Leach M, Lagman R (2003) Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manage 25(6):578\u2013582","journal-title":"J Pain Symptom Manage"},{"key":"3000_CR4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1099-1611(200001\/02)9:1<84::AID-PON440>3.0.CO;2-T","volume":"9","author":"WF Pirl","year":"2000","unstructured":"Pirl WF, Roth AJ (2000) Remission of chemotherapy-induced emesis with concurrent olanzapine treatment: a case report. Psychooncology 9:84\u201387","journal-title":"Psychooncology"},{"key":"3000_CR5","doi-asserted-by":"crossref","unstructured":"Abe M, Hirashima Y, Kasamatsu Y, Kado N, Komeda S, Kuji S et al. (2015) Efficacy and safety of olanzapine combined with aprepitant, palonosetron and dexamethasone for preventing nausea and vomiting by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1303 phase II trial. Supp Care Canc.\u00a0doi: 10.1007\/s00520-015-2829-z","DOI":"10.1007\/s00520-015-2829-z"},{"key":"3000_CR6","unstructured":"Park S, Choi C, Kwon M, Tae J, Kim H (2015) A phase II trial of palonosetron and olanzapine without dexamethasone for the prevention of chemotherapy-induced nausea and vomiting. Supp Care Canc 23(Suppl 1):S147"},{"key":"3000_CR7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00520-004-0755-6","volume":"13","author":"R Navari","year":"2005","unstructured":"Navari R, Einhorn L, Passik S, Loehrer P, Johnson C, Mayer M et al (2005) A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a hoosier oncology group study. Support Care Cancer 13:529\u2013534","journal-title":"Support Care Cancer"},{"key":"3000_CR8","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00520-007-0248-5","volume":"15","author":"R Navari","year":"2007","unstructured":"Navari R, Einhorn L, Loehrer P, Passik S, Vinson J, McClean J et al (2007) A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a hoosier oncology group study. Support Care Cancer 15:1285\u20131291","journal-title":"Support Care Cancer"},{"issue":"5","key":"3000_CR9","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0885-3924(03)00078-2","volume":"25","author":"S Passik","year":"2003","unstructured":"Passik S, Kirsh K, Theobald D, Dickerson P, Trowbridge R, Gray D et al (2003) A retrospective chart review of the use of olanzapine for the prevention of delayed emesis in cancer patients. J Pain Symptom Manage 25(5):485\u2013489","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"3000_CR10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1081\/CNV-200029066","volume":"22","author":"S Passik","year":"2004","unstructured":"Passik S, Navari R, Jong S, Nagy C, Vinson J, Kirsh K et al (2004) A phase I trial of olanzapine (zyprexa) for the prevention of delayed emesis in cancer patients: a hoosier oncology group study. Cancer Invest 22(3):383\u2013388","journal-title":"Cancer Invest"},{"issue":"6","key":"3000_CR11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0885-3924(02)00391-3","volume":"23","author":"S Passik","year":"2002","unstructured":"Passik S, Lundberg J, Kirsh K, Theobald D, Donaghy K, Holtsclaw E et al (2002) A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain. J Pain Symptom Manage 23(6):526\u2013532","journal-title":"J Pain Symptom Manage"},{"key":"3000_CR12","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1038\/srep04813","volume":"4","author":"X Wang","year":"2014","unstructured":"Wang X, Feng Y, Chen Y, Gao B, Han B (2014) A meta-analysis of olanzapine for the prevention of chemotherapy-induced nausea and vomiting. Sci Rep 4:4813","journal-title":"Sci Rep"},{"issue":"5","key":"3000_CR13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/appi.ajp.159.5.728","volume":"159","author":"H Mayberg","year":"2002","unstructured":"Mayberg H, Silva J, Brannan S, Tekell J, Mahurin R, McGinnis S et al (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatr 159(5):728\u2013737","journal-title":"Am J Psychiatr"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-3000-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-3000-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:09:47Z","timestamp":1559095787000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-3000-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["3000"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-3000-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}